Strides Pharma Science Ltd - Tight Range breakout

The stock has successfully broken above a key resistance at ₹1,025, a level that had previously capped upward moves.
After a retest of this zone, buyers stepped in, confirming the breakout and strengthening bullish sentiment.
A tight range breakout followed, signaling strong momentum and a shift from consolidation to expansion.
Current price action around ₹1,169 reflects sustained demand, with volume supporting the move.
Breakout Confirmation: Price has broken above the ₹1,025 resistance, retested, and continued higher.
Current Price: ₹1,169
🎯 Upside Targets (based on breakout momentum & measured move approach):
Target 1: ₹1,200 – psychological round number & near-term extension
Target 2: ₹1,250 – next resistance zone from prior swing highs
Target 3: ₹1,320 – projected move from tight range breakout
🛡️ Stop Loss:
Conservative: Below ₹1,100 (recent retest zone support)
Aggressive: Below ₹1,025 (original breakout level, invalidation point)
After a retest of this zone, buyers stepped in, confirming the breakout and strengthening bullish sentiment.
A tight range breakout followed, signaling strong momentum and a shift from consolidation to expansion.
Current price action around ₹1,169 reflects sustained demand, with volume supporting the move.
Breakout Confirmation: Price has broken above the ₹1,025 resistance, retested, and continued higher.
Current Price: ₹1,169
🎯 Upside Targets (based on breakout momentum & measured move approach):
Target 1: ₹1,200 – psychological round number & near-term extension
Target 2: ₹1,250 – next resistance zone from prior swing highs
Target 3: ₹1,320 – projected move from tight range breakout
🛡️ Stop Loss:
Conservative: Below ₹1,100 (recent retest zone support)
Aggressive: Below ₹1,025 (original breakout level, invalidation point)
Dagangan ditutup: sasaran tercapai
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.